Ⓐ
PeptiBrief
Observational study· 2013

Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus

Topuz M|Celik A|Aslantas T|Demir AK|Aydin S|Aydin S

Journal of Investigative Medicine

DOI
10.2310/jim.0000000000000003
PubMed
24113736
Evidence level
weak
Verification
verified

Summary

An observational study measured adropin and flow-mediated dilation in adults with type 2 diabetes.

Limitations

Observational design|No therapeutic intervention|Single clinical population|Association cannot prove causation

Linked peptides

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.